We evaluated the bactericidal activities of 35 benzaldehydes, 34 benzoic acids, and 1 benzoic acid methyl ester against Campylobacter jejuni, Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella enterica when these compounds were substituted on the benzene ring with 0, 1, 2, or 3 hydroxy (OH) and/or methoxy (OCH 3 ) groups in a pH 7.0 buffer. Dose-response plots were used to determine the percentage of the sample that induced a 50% decrease in CFU after 60 min (BA 50 ). Of the 70 compounds tested, 24 were found to be active against all four pathogens, and additional 4, 10, and 12 were found to be active against three, two, and one of the pathogens, respectively. C. jejuni was ;100 times as sensitive as the other three pathogens. The 10 compounds that were most active against the four pathogens (with average BA 50 values ranging from 0.026 to 0.166) and are candidates for studies of activity in foods or for disinfections were 2,4,6-trihydroxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2,3,4-trihydroxybenzaldehyde, 2-hydroxy-5-methoxybenzaldehyde, 2,3-dihydroxybenzaldehyde, 2-hydroxy-3-methoxybenzaldehyde, 4-hydroxy-2,6-dimethoxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2,4-dihydroxybenzaldehyde, and 2-hydroxybenzaldehyde. Comparison of the chemical structures of the test compounds and their activities revealed that (i) the aldehyde (CHO) group was more active than the carboxyl (COOH) group whether or not OH groups were present; (ii) compounds were most active with trisubstituted OH . disubstituted OH . monosubstituted OH; (iii) for disubstituted derivatives, 2-OH enhanced activities were exhibited by benzaldehyde but not by benzoic acid; (iv) compounds were more active with OH than with OCH 3 , irrespective of the position of substitution on the benzene ring; (v) compounds with mixed OH and OCH 3 groups exhibited variable results, i.e., in some cases OCH 3 groups enhanced activity and in other cases they did not; (vi) methoxybenzoic acids were largely inactive; and (vii) gallic acid was 20 times as active against S. enterica at pH 7.0 as it was at pH 3.7, suggesting that the ionization of its OH groups may enhance bactericidal activity.
Pathogenic strains of Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica are linked to foodborne illnesses. Nontoxic food-compatible natural products are a source of compounds that may be useful in interventions to reduce pathogens on surfaces of fruits and vegetables and in antimicrobial formulations added to foods such as fruit and vegetable juices, meat, and poultry for disinfection or to minimize the contamination of these foods during storage and during commercial and home processing.
Phenolic compounds are secondary plant metabolites found in numerous plant species, and they play key roles in the biochemistry and physiology of plants. These compounds, especially oxidation products of phenolic compounds, appear to be involved in the defense of plants against invading pathogens, including bacteria, fungi, and viruses. In addition, polyphenol-oxidase-catalyzed polymerization of monomeric phenols such as chlorogenic acid helps to seal the injured plant surface and initiates the healing process, analogous to the formation of brin blood clots in injured animals and humans (12) .
Dietary phenolic compounds have also been shown to have numerous bene cial properties by virtue of their ability to act as antioxidants, anticarcinogens, antimutagens, and antiglycemic agents (19, 27, 37, (40) (41) (42) . These properties can be used in the prevention of rancidity in food and in the development of health-promoting food ingredients. However, phenolic compounds can also darken protein-containing food ingredients and reduce the nutritional quality of protein through their ability to participate in polyphenol-protein enzymatic browning reactions catalyzed by polyphenol oxidases (11, 13) .
In addition to their cited bene cial effects, phenolic compounds are also reported to have antimicrobial activities against human pathogens. The literature contains numerous studies on the antibacterial, antifungal, and antiviral activities of natural and synthetic phenolic compounds (1-5, 7-9, 16, 18, 20, 23-25, 27, 29, 31-35, 39, 44, 45) , and these studies go back to the 19th century following the discovery by Lister and others that carbolic acid (phenol) can act as an antibiotic against wound infections (21) . As described in detail in the excellent reviews by Davidson (6) and Fung et al. (17) , the synthetic methyl and propyl esters of p-hydroxybenzoic acid, the so-called parabens, as well as tertiary butylhydroxyanisole (BHA) and tertiary butylhydroquinone (TBC), are on the generally-recognized-assafe list for use in food at a maximum concentration of Table 1 shows the positions of the OH and OCH 3 groups on the benzene rings. 0.02% (38) . However, they appear not to be widely used, possibly because of their low solubility in water.
To assess the antimicrobial potential of natural compounds and plant extracts, we previously evaluated the relative bactericidal activities of 96 plant essential oils and 23 of their active components by testing them separately against the four major human pathogens (14) . In addition, we have been evaluating other compounds in a broad effort to de ne the chemical basis for the antimicrobial activities of different classes of natural products. As part of this effort, the general objective of the present study was to screen a variety of benzaldehydes and benzoic acids substituted on the benzene ring with one, two, and three OH and/or OCH 3 groups (Fig. 1 ). The data obtained in this study indicate that the benzaldehydes are more active than the benzoic acids and that bactericidal activities are in uenced by both the number and the position of the OH and OCH 3 groups on the benzene rings.
MATERIALS AND METHODS
Test compounds. The following compounds were purchased from Sigma (St. Louis, Mo.) or Aldrich (Milwaukee, Wis.) (the common names are followed by molecular weights of the compounds in parentheses): benzaldehyde (106); benzoic acid (122); acetylsalicylic acid (aspirin, 180); 2-hydroxybenzaldehyde (salicylaldehyde, 122); 2-hydroxybenzoic acid (salicylic acid, 138); 2methoxybenzaldehyde (o-anisaldehyde, 136); 2-methoxybenzoic acid (o-anisic acid, 152); 3-hydroxybenzaldehyde (122); 3-hydroxybenzoic acid (138); 3-methoxybenzaldehyde (m-anisaldehyde, 136); 3-methoxybenzoic acid (m-anisic acid, 152); 4-hydroxybenzaldehyde (122); 4-hydroxybenzoic acid (138); 4-methoxybenzaldehyde (p-anisaldehyde, 136); 4-methoxybenzoic acid (p-anisic acid, 152); 2,3-dihydroxybenzaldehyde (138); 2,3-dihydroxybenzoic acid (154); 2,3-dimethoxybenzaldehyde (166); 2,3dimethoxybenzoic acid (182); 2,4-dihydroxybenzaldehyde (b-resorcylaldehyde, 138); 2,4-dihydroxybenzoic acid (b-resorcylic acid, 154); 2,4-dimethoxybenzaldehyde (166); 2,4-dimethoxybenzoic acid (182); 2,5-dihydroxybenzaldehyde (gentisaldehyde, 138); 2,5-dihydroxybenzoic acid (gentisic acid, 154); 2,5-dimethoxybenzaldehyde (166); 2,5-dimethoxybenzoic acid (182); 2,6dihydroxybenzoic acid (g-resorcylic acid, 154); 2,6-dimethoxybenzaldehyde (166); 2,6-dimethoxybenzoic acid (182); 2-hydroxy-3-methoxybenzaldehyde (o-vanillin, 152); 2-hydroxy-3methoxybenzoic acid (3-methoxysalicylic acid, 168); 2-hydroxy-4-methoxybenzaldehyde (4-methoxysalicylaldehyde, 152); 2-hydroxy-4-methoxybenzoic acid (4-methoxysalicylic acid, 168); 2-hydroxy-5-methoxybenzaldehyde (5-methoxysalicylaldehyde, 152); 2-hydroxy-5-methoxybenzoic acid (5-methoxysalicylicacid, 168); 2-hydroxy-6-methoxybenzoic acid (6-methoxysalicylicacid, 168); 3,4-dihydroxybenzaldehyde (protocatechualdehyde, 138); 3,4-dihydroxybenzoic acid (protocatechuic acid, 154); 3,4-dimethoxybenzaldehyde (veratraldehyde, 166); 3,4-dimethoxybenzoic acid (veratric acid, 182); 3,5-dihydroxybenzaldehyde (138); 3,5dihydroxybenzoic acid (a-resorcylic acid, 154); 3,5-dimethoxybenzaldehyde (168); 3,5-dimethoxybenzoic acid (182); 3-hydroxy-4-methoxybenzaldehyde (isovanillin, 152); 3-hydroxy-4methoxybenzoic acid (isovanillic acid, 168); 4-hydroxy-3-methoxybenzaldehyde (vanillin, 152); 4-hydroxy-3-methoxybenzoic acid (vanillic acid, 168); 2,3,4-trihydroxybenzaldehyde (154); 2,3,4-trihydroxybenzoic acid (170); 2,3,4-trimethoxybenzaldehyde (196); 2,3,4-trimethoxybenzoic acid (212); 2,4,5-trimethoxybenzaldehyde (196); 2,4,5-trimethoxybenzoic acid (asaronic acid, 212); 2,4,6-trihydroxybenzaldehyde (phloroglucinocarboxaldehyde, 154); 2,4,6-trihydroxybenzoic acid monohydrate (188); 2,4,6trimethoxybenzaldehyde (196); 3,4,5-trihydroxybenzaldehyde monohydrate (172); 3,4,5-trihydroxybenzoate methyl ester (gallic acid methyl ester, 184); 3,4,5-trihydroxybenzoic acid (gallic acid, 170); 3,4,5-trimethoxybenzaldehyde (196); 3,4,5-trimethoxybenzoic acid (212); 2-hydroxy-4,6-dimethoxybenzaldehyde (182); 3hydroxy-4,5-dimethoxybenzoic acid (182); 3,4-dihydroxy-5-methoxybenzaldehyde (168); 4-hydroxy-2,6-dimethoxybenzaldehyde (182); 4-hydroxy-3,5-dimethoxybenzaldehyde (syringaldehyde, 182); 4-hydroxy-3,5-dimethoxybenzoic acid (syringic acid, 198); and 5-hydroxy-3,4-dimethoxybenzaldehyde (182). Standard test compounds included trans-cinnamaldehyde, gentamycin, and chloramphenicol (Sigma). All compounds were purported to be 96 to 99% pure.
Test buffers. Phosphate-buffered saline (PBS, pH 7.0) was prepared by mixing dibasic sodium phosphate (100 mM) and monobasic sodium phosphate (100 mM) at a 2:1 ratio, diluting by half with H 2 O, and adding NaCl (150 mM). For stronger buffering, the benzoic acids were prepared in 200 mM PBS (pH 7.0) buffer. For the pH study, the PBS buffer (pH 7.0) was adjusted to pH 8.4 with 5 N NaOH, and a 2 mM citric acid-150 mM NaCl buffer was adjusted to pH 3.7 or pH 5.4.
Test solutions.
Test solutions or suspensions were prepared by adding 10 ml of liquid test compound or 10 to 15 mg of solid test compound to 1 ml of buffer and vortexing for 1 min. If they were insoluble, the solutions were microwaved for 4 to 5 s on the high setting so that condensation on the tube was observed but volume was not lost. The samples were vortexed for 1 min and shaken.
Suspended stock solutions were shaken vigorously by hand in 1.9-ml sterile plastic snap-cap microcentrifuge tubes. A 200-ml aliquot was added to 400 ml of buffer and then shaken vigorously prior to the addition of the next aliquot. For E. coli, S. enterica, and L. monocytogenes, the samples were diluted threefold, and for C. jejuni, the samples were diluted fourfold for each of six dilutions, respectively. The antibiotic gentamycin was used as a positive control for C. jejuni, E. coli, and S. enterica, and the antibiotic chloramphenicol was used as a positive control for L. monocytogenes. On the basis of our extensive experience with cinnamaldehyde (14) , this compound was also used as a positive control for C. jejuni, E. coli, and S. enterica.
Sources of bacteria. C. jejuni RM1221, E. coli O157:H7 strain RM1484, L. monocytogenes RM2199, and S. enterica ser-ovar Hadar strain RM1309, obtained from contaminated food and clinical sources and described previously (14) , were used in this study.
Bactericidal assays. The bactericidal assay was developed by modifying a previously described microtiter plate bactericidal assay (14) . Brie y, C. jejuni was cultured on iron-supplemented brucella agar (BA) (Difco Laboratories, Sparks, Md.) in Hefty One-Zip Slider Freezer bags (Hefty, Lake Forest, Ill.) lled with a microaerophilic gas mixture (5% O 2 , 10% CO 2 , and 85% N 2 ) for 18 to 19 h at 428C. The bags were lled with gas, the gas was expelled three times, and then the bags were sealed tightly to ensure the proper atmosphere. Streaked plates, rather than broth cultures, were used as the source of C. jejuni. E. coli and S. enterica were cultured in Luria-Bertani agar broth (Difco) for 16 to 18 h at 378C, and L. monocytogenes was cultured in iron-supplemented brain heart infusion broth (Difco) for 16 to 18 h at 378C.
A 1-ml sample of stationary-phase bacteria (E. coli, S. enterica, or L. monocytogenes) in broth was centrifuged, and the pellet was resuspended in 1 ml of sterile PBS. The sample's optical density at 620 nm (OD 620 ) was adjusted to ca. 0.8 with PBS. Each 10-ml sample was added to 990 ml of PBS (1:100), and then 80 ml of the 1:100 sample was diluted in 20 ml of PBS to a nal dilution of 1:25,000 containing ca. 1,500 to 2,000 cells.
Studies to optimize the bactericidal assay for the microaerophilic C. jejuni were carried out. Speci cally, colonies on plates from 16-to 18-h cultures were sampled with a loop and suspended in 1 ml of PBS. The bacterial suspension was centrifuged, and the pellet was resuspended in PBS. The OD 620 of the suspension was adjusted to 1.0 to 1.3. The diluted sample (10 ml) was added to 990 ml of PBS (1:100), and then 20 ml of the 1:100 sample was diluted in 20 ml of PBS to a nal dilution of 1:100,000.
The assay mixture consisted of PBS buffer (pH 7.0), the test compound, and the bacteria. For the pH studies with S. enterica, 20 ml of the 1:100 sample was diluted in 5 ml of PBS (pH 8.4 or pH 7.0) or citric acid-saline (pH 5.4 or pH 3.7).
Samples were prepared with sterile 96-well tissue culture microtiter plates (Nalge, Nunc International, Rochester, N.Y.). Each dilution was shaken prior to its addition to the wells. The addition of 100 ml of PBS minus/plus test substance to the wells was followed by the addition of 50 ml of bacterial suspension; thus, the original stock solution was diluted by one-third. Six wells were used for each control to obtain an average control value; one positive control (gentamycin, chloramphenicol, or trans-cinnamaldehyde) was represented in a dilution series across six wells, and 14 test compounds were represented in dilution series across the remaining wells. The wells on the plate were covered with a SealPlate cover (Marsh Bioproducts, Rochester, N.Y.), sealed on the outside edges with Para lm, and then incubated with gentle shaking for 60 min at 378C (428C for C. jejuni). For the pH studies, S. enterica was incubated for 30 and 60 min at 378C.
Following incubation, a 20-ml sample from each well was spotted at the top of a square petri dish containing Luria-Bertani medium (for E. coli and S. enterica), brain heart infusion agar (for L. monocytogenes), or iron-supplemented BA (for C. jejuni). Six 20-ml spots were spaced across the top-one for each dilution of test sample or six controls. The plates were placed uncovered in a biological safety hood until the sample liquid dried (ca. 10 min) and were then covered. E. coli, S. enterica, and L. monocytogenes plates were incubated overnight at 378C. C. jejuni plates were placed in sealable bags lled with gas (5% O 2 , 10% CO 2 , and 85% N 2 ) and incubated at 428C. E. coli, S. enterica, and L. monocytogenes colonies were counted after 18 to 24 h. C. jejuni CFU in iron-supplemented BA were usually small but were counted at 24 h. We also observed a purplish black staining of the iron-supplemented BA with some of the compounds. The benzaldehydes and gallic acid used in the pH studies were observed to be chromogenic at neutral and alkaline pHs. Experimental results were analyzed only when control counts were 60 to 200 CFU. In each case, at least two separate experiments, involving bacterial pellets processed from two different cultures, were performed.
Bactericidal activity. Bactericidal activity was de ned as the percentage of test compound that kills 50% of the bacteria after 60 min (BA 50 ) and was determined as follows (14) . Each compound was tested as a series of six dilutions from 0.00065 to 0.67% in the reaction mixture. The CFU counts for all experiments were transferred to a Microsoft Excel 8.0 Spreadsheet. The number of CFU from each dilution was matched with the average control value to determine the percentage of bacteria killed per well. Each of the dose-response pro les (percentage of test compound versus percentage of bactericidal activity) was examined graphically, and the BA 50 values were estimated by a linear regression (36) . The lower the BA 50 value or the higher the 1/BA 50 value, the higher the activity. A BA 50 value of .0.67% considered to indicate inactivity. Table 1 shows the BA 50 values for benzaldehyde, benzoic acid, and 68 derivatives substituted with OH, OCH 3 , and both groups in various positions of the benzene ring. The observed solubilities and colors of these compounds are also given in the Table 1 . Four types of preparations were observed: solutions; suspensions; milky, oily suspensions; and immiscible oils with rapid oil separation. The 5s microwaving used to facilitate solubilization should not affect these compounds in view of reports that microwaves do not adversely affect the nutrition and safety of different categories of food ingredients (10) .
RESULTS
Under the test conditions, benzoic acid was inactive against all four bacteria (BA 50 . 0.67). In contrast, benzaldehyde was highly active against C. jejuni (BA 50 5 0.045) and less active against the other three bacteria (with BA 50 values ranging from 0.36 to 0.48).
To facilitate discussion of the effects of structure on antimicrobial activity, Figure 2 shows plots of 1/BA 50 values (calculated from the BA 50 values listed in Table 1 ) for the 10 compounds that were most active against each of the four pathogens. Table 2 lists average BA 50 values for the 24 compounds active against all four species, and Table  3 presents data on the effects of pH on the bactericidal activities of selected compounds. Figure 3 depicts so-called box-and-whisker plots, wellestablished statistical tools (26, 43) that allow the visualization of the trends and distributions of activities against the four pathogens (1/BA 50 values) for all 70 compounds listed in Table 1 . The description of these results will be divided into three parts, covering monosubstituted, disubstituted, and trisubstituted compounds as listed in Table 1 .
Monosubstituted benzaldehydes and benzoic acids.
2-Hydroxybenzaldehyde (salicylaldehyde) was quite active against all four bacteria, with BA 50 values ranging from 0.064 to 0.26. In contrast, 2-hydroxybenzoic (salicylic) acid showed only borderline activity against the four bacteria. The corresponding 2-methoxybenzoic acid was inactive. Acetylation of the 2-OH group of benzoic acid forms the inactive acetylsalicylic acid (aspirin). Surprisingly, methylation of the 2-OH group of 2-hydroxybenzaldehyde to form 2-methoxybenzaldehyde (o-anisaldehyde) resulted in a decrease in, but not the elimination of, antibacterial activity (with BA 50 values ranging from 0.19 to 0.66).
With regard to the substitutions in the 3 positions of the benzene rings, we found that the BA 50 values for 3hydroxybenzaldehyde ranged from 0.20 to 0.37, whereas 3hydroxybenzoic acid was inactive. The BA 50 values for 3methoxybenzaldehyde (m-anisaldehyde) ranged from 0.091 to .0.67, whereas 3-methoxybenzoic acid was inactive.
For compounds with substituents in the 4 position, the BA 50 values for 4-hydroxy-benzaldehyde ranged from 0.20 to 0.41, and those for 4-methoxybenzaldehyde (p-anisaldehyde) ranged from 0.068 to 0.58. Both 4-hydroxy-and 4-methoxybenzoic acids were inactive.
Disubstituted benzaldehydes and benzoic acids.
Disubstituted benzaldehydes and benzoic acids will be described in the following order: 2,3-, 2,4-, 2,6-, 3,4-, and 3,5-disubstituted derivatives with either OH or OCH 3 groups followed by compounds with both OH and OCH 3 substituents. Table 1 shows that 2,3-dihydroxybenzaldehyde was highly active against all four bacteria (with BA 50 values ranging from 0.016 to 0.11). The corresponding 2,3dihydroxybenzoic acid was active only against C. jejuni (BA 50 5 0.31) and was inactive against the other three bacteria. Again, the activity level of 2,3-dimethoxybenzaldehyde (with BA 50 values ranging from 0.29 to 0.58) was Table 1 .
lower than that for the corresponding dihydroxy compound. 2,3-Dimethoxybenzoic acid was inactive. The data for 2,4-disubstituted compounds show that (i) the BA 50 values for 2,4-dihydroxybenzaldehyde ranged from 0.065 to 0.35; (ii) 2,4-dihydyroxybenzoic acid was active against C. jejuni (BA 50 5 0.46) but not against the other three bacteria; and (iii) 2,4-dimethoxybenzaldehyde exhibited activity against C. jejuni (BA 50 5 0.38) but not against the other three bacteria. These results show that the activities of the 2,4-disubstituted benzaldehydes are similar to those of the corresponding 2,3 compounds. Both are more active than the monosubstituted compounds.
The activity level of 2,5-dihydroxybenzaldehyde (gentisaldehyde) (with BA 50 values ranging from 0.017 to 0.063) appears higher than that described above for the 2,3and 2,4-disubstituted analogs. 2,5-Dihydroxybenzoic acid (gentisic acid) was active against C. jejuni (BA 50 5 0.20) and S. enterica (BA 50 5 0.48) but not against the other two bacteria. 2,5-Dimethoxybenzaldehyde was also active against C. jejuni (BA 50 5 0.36) and S. enterica (BA 50 5 0.40) but not against the other two bacteria. 2,5-Dimethoxybenzoic acid was inactive against all four bacteria.
The 2,6-dihydroxybenzaldehyde isomer was not available to us. Table 1 shows that the corresponding 2,6-dihy-droxybenzoic acid (g-resorcylic acid) was active against C. jejuni (BA 50 5 0.40) and S. enterica (BA 50 5 0.47) but not against the other two bacteria. 2,6-Dimethoxybenzaldehyde was active against all four bacteria (with BA 50 values ranging from 0.15 to 0.66), whereas 2,6-dimethoxybenzoic acid was inactive against all four bacteria.
3,4-Dihydroxybenzaldehyde (protocatechualdehyde) was highly active against C. jejuni (BA 50 5 0.0031) and less active against the other three bacteria (with BA 50 values ranging from 0.22 to 0.33). 3,4-Dihydroxybenzoic acid (protocatechuic acid) was active against C. jejuni (BA 50 5 0.11) and S. enterica (BA 50 5 0.50) and inactive against the other two bacteria. 3,4-Dimethoxybenzaldehyde (veratraldehyde) was active against L. monocytogenes (BA 50 5 0.29) and C. jejuni (BA 50 5 0.48) and inactive against the other two bacteria. 3,4-Dimethoxybenzoic acid was inactive against all four bacteria.
3,5-Dihydroxybenaldehyde showed high levels of activity against all four bacteria (with BA 50 values ranging from 0.065 to 0.19). 3,5-Dimethoxybenzaldehyde was active against C. jejuni (BA 50 5 0.088) and S. enterica (BA 50 5 0.65) and inactive against the other two bacteria. 3,5-Dihydroxybenzoic acid was inactive against all four bacteria, whereas 3,5-dimethoxybenzoic acid was active against C. jejuni (BA 50 5 0.28) and inactive against the other three species.
The data for the mixed hydroxy-methoxy substitutions show the following trends in activity. 2-Hydroxy-3-methoxybenzaldehyde (o-vanillin) showed substantial activity against all four bacteria (with BA 50 values ranging from 0.012 to 0.25), whereas 2-hydroxy-3-methoxybenzoic acid was active only against C. jejuni (BA 50 5 0.45). 2-Hydroxy-4-methoxybenzaldehyde was active against all four bacteria (with BA 50 values ranging from 0.0025 to 0.43), whereas 2-hydroxy-4-methoxybenzoic acid was active only against C. jejuni (BA 50 5 0.53). The BA 50 values for the highly active 2-hydroxy-5-methoxybenzaldehyde ranged from 0.00066 for C. jejuni to 0.070 for E. coli to 0.10 for L. monocytogenes to 0.19 for S. enterica. 2-Hydroxy-5methoxybenzoic acid was active against C. jejuni (BA 50 5 0.057) and inactive against the other three bacteria, as was also the case for 2-hydroxy-6-methoxybenzoic acid (with a BA 50 value of 0.18 for C. jejuni). 4-Hydroxy-3-methoxybenzaldehyde (vanillin) was active against C. jejuni (BA 50 5 0.073) and less active against the other three bacteria (with BA 50 values ranging from 0.53 to 0.63), whereas 3hydroxy-4-methoxybenzaldehyde (isovanillin) was slightly active against S. enterica (BA 50 5 0.61) and inactive against the other three pathogens. 4-Hydroxy-3-methoxybenzoic acid (vanillic acid) and 3-hydroxy-4-methoxybenzoic acid (isovanillic acid) were inactive against all four species.
Trisubstituted benzaldehydes and benzoic acids. 2,3,4-Trihydroxybenzaldehyde was highly active, as evidenced by BA 50 values ranging from 0.0037 to 0.20 for the four bacteria. The corresponding 2,3,4-trihydroxybenzoic acid was active against C. jejuni (BA 50 5 0.046) and S. enterica (BA 50 5 0.11), slightly active against E. coli (BA 50 5 0.66), and inactive against L. monocytogenes. 2,3,4-Trimethoxybenzaldehyde exhibited a low level of activity (with BA 50 values ranging from 0.53 to 0.64). 2,3,4-Trimethoxybenzoic acid was inactive against all four bacteria. Both 2,4,5-trimethoxybenzaldehyde and 2,4,5-trimethoxybenzoic acid were inactive against all four species.
2,4,6-Trihydroxybenzaldehyde was highly active against all four bacteria (with BA 50 values ranging from 0.008 to 0.055), whereas 2,4,6-trimethoxybenzaldehyde showed a high level of activity against C. jejuni (BA 50 5 0.011) and low levels of activity against the other three bacteria. The corresponding 2,4,6-trimethoxybenzoic acid was inactive against all four pathogens.
The data for the 3,4,5 series show that 3,4,5-trihydroxybenzaldehyde was inactive against L. monocytogenes but highly active against the other three organisms (with BA 50 values ranging from 0.0026 to 0.054). Gallic acid (3,4,5trihydroxybenzoic acid) was active against C. jejuni (BA 50 5 0.0049) and S. enterica (BA 50 5 0.038) but not against E. coli and L. monocytogenes. Esteri cation of the carboxyl group of gallic acid to form 3,4,5-trihydroxybenzoate methyl ester (methylparaben) resulted in BA 50 values of 0.0093 for C. jejuni, 0.19 for L. monocytogenes, 0.30 for S. enterica, and 0.38 for E. coli. 3,4,5-Trimethoxybenzaldehyde was inactive against all four bacteria. 3,4,5-Trimethoxybenzoic acid was active against C. jejuni (BA 50 5 0.43) and inactive against the other three species.
With respect to the mixed hydroxy-methoxy trisubstituted compounds, the results obtained in this study show that 2-hydroxy-4,6-dimethoxybenzaldehyde was active only against C. jejuni (BA 50 5 0.038). 3,4-Dihydroxy-5-methoxybenzaldehyde was active against all four bacteria (with BA 50 values ranging from 0.0033 to 0.51), and 3-hydroxy-4,5-dimethoxybenzoic was active only against C. jejuni (BA 50 5 0.047). 4-Hydroxy-2,6-dimethoxybenzaldehyde was active against all four pathogens (with BA 50 values ranging from 0.0078 to 0.47), 4-hydroxy-3,5-dimethoxybenzaldehyde (syringaldehyde) was active only against C. jejuni (BA 50 5 0.031) and S. enterica (BA 50 5 0.58), and 4-hydroxy-3,5-dimethoxybenzoic acid was inactive. 5-Hydroxy-3,4-dimethoxybenzaldehyde was active against all four species (with BA 50 values ranging from 0.37 to 0.55).
To facilitate the application of the data to foods, Figure  2 shows the bactericidal activity levels of the 10 compounds that were most active against each of the four pathogens. For C. jejuni, BA 50 values ranged from 0.0007 for 2-hydroxy-5-methoxybenzaldehyde to 0.0093 for 3,4,5trihydroxybenzoate methyl ester; for E. coli, BA 50 values ranged from 0.042 for 3,4,5-trihydroxybenzaldehyde to 0.160 for 3,5-dihydroxybenzaldehyde; for L. monocytogenes, BA 50 values ranged from 0.009 for 2,4,6-trihydroxybenzaldehyde to 0.350 for 2,4-dihydroxybenzaldehyde; and for S. enterica, BA 50 values ranged from 0.029 for 2,3,4trihydroxybenzaldehyde to 0.140 for 3-methoxybenzaldehyde. To further facilitate the application of the data to foods contaminated with multiple strains of human pathogens, Table 2 lists the average BA 50 values for the 24 compounds that were active against all four bacteria. These BA 50 values range from 0.026 for 2,4,6-trihydroxybenzaldehyde to 0.585 for 2,3,4-trimethoxybenzaldehyde. pH effects. Since pH can affect both the susceptibility of S. enterica to inactivation (22) and the ionization of the OH groups of the test compounds (15) , additional exploratory studies were carried out to ascertain to what extent, if any, the pH of the medium would in uence antibacterial activities against this pathogen. The limited data shown in Table 2 suggest that pH has a variable effect on the antimicrobial activities of the six compounds evaluated at pHs ranging from 3.7 to 7.0. Gallic acid was an exception. Its activity increased about 20-fold after 60 min when the pH was increased from 3.7 to 7.0. Attempts to determine activities at pH 8.4 were unsuccessful. The results were not reproducible, presumably because of the sensitivity of the microorganisms in the control samples to inactivation at the higher pH.
DISCUSSION
Structural and mechanistic aspects. The structurefunction analysis of the compounds tested in this study contributes to efforts designed to elucidate the effects of structures and action mechanisms of antibacterial activities for this class of compounds. The requirement of the phenolic OH group for antimicrobial activity is strikingly demonstrated by the observation (44) that the phenolic OH group of carvacrol is essential for activity against Bacillus cereus, since cymene, a biological precursor of carvacrol lacking the OH group, had a much less extensive effect on the membrane potential associated with bactericidal activity than did carvacrol. In relevant studies, Ramos-Nino et al. (31) describe quantitative structure-activity relationships for several benzaldehydes with regard to the activities of these compounds against L. monocytogenes, Salmonella Enteritidis, and Lactobacillus plantarum. Multiregression analysis of the data and arti cial neural network models showed that steric and polar parameters of the benzaldehydes were important but a lipophilic parameter was not. These ndings suggest that rather than disrupting cell membranes, the compounds acted outside the cell. Additional chemical studies indicated that the benzaldehydes became covalently attached to surface SH groups of the bacterial cells (31) .
Ramos-Nino et al. (30) also used mathematical relationships to describe the inhibition of a cocktail of 18 strains of L. monocytogenes in terms of steric and electronic effects associated with substituted benzoic and cinnamic acids and benzaldehydes. It is noteworthy that the mathematical model used to predict the activities of the pure compounds could not predict their activities in milk, meat, or soups. Activities against Listeria in these foods were generally lower than those observed in vitro. Payne et al. (28) also evaluated the antimicrobial activities of phenolic compounds against L. monocytogenes in milk.
Our results show that the aldehyde (CHO) group of benzaldehyde, but not the carboxyl (COOH) group of benzoic acid, is a structural feature that can contribute to antimicrobial activity in the absence of any phenolic OH groups on the benzene ring. Our data also show that the monosubstituted phenolic derivatives of benzaldehyde are much more active than the parent unsubstituted compounds. The results of the present study also revealed the following order of bactericidal activity intensities elicited by the phenolic compounds (with some exceptions): trisubstituted OH . disubstituted OH . monosubstituted OH. For disubstituted derivatives, the 2-OH and 4-OH groups enhance the antimicrobial activities of benzaldehyde but not those of benzoic acid. Both the 2-OCH 3 and the 4-OCH 3 substitutions also increased activity levels for benzaldehyde. However, the increase for the methoxy groups was smaller than that for the corresponding hydroxy groups. Compounds with three methoxy groups were inactive. Compounds with mixed OH and OCH 3 groups exhibited variable results, i.e., in some cases the added methoxy groups enhanced activity and in others they had no effect.
The esteri cation of gallic acid to 3,4,5-trihydroxybenzoate methyl ester results in a signi cant increase in activity. This increase is presumably the basis for the extensive studies on the antimicrobial properties of the numerous synthetic gallic acid esters mentioned below. Antibacterial activities of gallic acid esters of different chain lengths are related to the length of the alkyl group of the ester side chain (16) . The inhibition of oxygen use by methyl esters of hydroxycinnamates (alkacins) was found to be correlated with growth inhibition when hydroxycinnamates were tested against Pseudomonas uorescens (2) . These results suggest that bacteriostatic activities of phenolic compounds are based on cellular energy depletion and not on membranedisrupting effects.
An examination of the trends in activities shown in Tables 1 and 2 and Figures 2 and 3 indicates similar distributions and clusterings of activities for E. coli, S. enterica, and L. monocytogenes. In contrast, levels of activity against C. jejuni were approximately 100 times as high as the observed levels of activity against the other three species. The plots also show a much broader distribution of activities against C. jejuni. We do not know the reasons for these differences. The summary of the activities for the 24 compounds that were active against all four species, presented in Table 2 , will be helpful in devising antibacterial formulations with which to protect food and possibly also nonfood substrates against multiple pathogens.
Effect of pH on bactericidal activities of phenolic compounds.
The ionization of a phenolic group to a phenoxide ion (ROH ® RO 2 1 H 1 ) is governed by its pK a values as well as by the pH of the medium. The higher the pH, the more extensive the ionization. Since pK values of phenolic OH groups are usually .8 (15) , the concentration of phenoxide ions is low at pH values of ,7. Thus, if phenoxide ions rather than the protonated forms are the active antibacterial species, expectations are that activities of the phenolic compounds should increase with pH. It is therefore of inherent interest to nd out whether the antibacterial activity levels of phenoxide ions (RO 2 ) are higher than those of the protonated forms (ROH). If they are, the enhancement of activity when the medium's pH is higher probably arises from the negative charge of the phenoxide ions. These charges may alter the electrochemical balance in proximity to the microenvironment of the bacteria, facilitating cell death.
Exploratory studies summarized in Table 3 show that activity appears to increase as the pH increases from 3.7 to 7.0. However, except for gallic acid, this increase appears not to be signi cant in the narrow pH range studied. For gallic acid, the BA 50 value decreased from 0.20 at pH 3.7 to 0.035 at pH 7.0 after 30 min (a sixfold increase in activity). The corresponding change after 60 min was from 0.19 to 0.0093, a highly signi cant 20-fold increase in activity. Expectations were that this trend would accelerate at higher pH values. However, our efforts to measure antimicrobial activity at pH 8.4 were unsuccessful because the high pH killed signi cant amounts of the bacteria in the control sample. In related studies, we found that certain antibacterial phenolic compounds such as gallic acid are themselves unstable at high pHs (15) . Since many foods, such as fruit and vegetable juices, vinegar salad dressings, and sweet and sour sauces, are on the acid side of the pH scale, the effect of pH on the antibacterial activities of phenolic compounds merits further study (9, 22, 32) .
CONCLUSIONS
We have reported the antibacterial activities of a variety of phenolic benzaldehydes and benzoic acids against four human pathogens. The bactericidal assay was easy to perform, and the results were reproducible in assays with the same samples tested at different times. The ultimate goal of these studies is to develop a better understanding of the structural features of phenolic compounds that govern antibacterial activities as well as to devise food formulations that use the active compounds to reduce pathogens in foods, feeds, and possibly also in animals and humans after the consumption of contaminated foods. Studies involving foods need to take into account safety (38) , solubility (Table 1) , and sensory properties, including the color and avor of the test compounds, as well as effects of the food matrix and of storage temperatures and times on antibacterial activities. The possible use of these compounds for the disinfection of nonfood substrates, e.g., meat cutting boards, also merits study.
